Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage...

Area of Science:

• Immunology
• Molecular Biology
• Renal Medicine

Background:

• The complement system is crucial for innate immunity but requires tight regulation to prevent self-damage.
• Complement receptor 1 (CR1) is a key regulator of complement activation, primarily studied on blood cells.
• CR1's expression on kidney podocytes suggests a role in renal complement-mediated diseases, but its epithelial function is unclear.

Purpose of the Study:

• To investigate the specific functions of Complement receptor 1 (CR1) on epithelial cells.
• To determine CR1's efficacy in regulating complement pathways and handling immune complexes in an epithelial context.

Main Methods:

• Utilized a Chinese hamster ovary (CHO) cell model system engineered to express CR1.
• Assessed CR1's impact on C3b deposition during classical and alternative complement pathway activation.
• Evaluated CR1's decay accelerating activity, cofactor activity, and immune complex binding capabilities.

Main Results:

• CR1 significantly reduced C3b deposition by approximately 80% in the classical pathway and over 95% in the alternative pathway.
• CR1 exhibited potent decay accelerating activity and cofactor activity, cleaving deposited C4b and C3b to C4d and C3d.
• CR1 functioned intrinsically, bound immune complexes stably without internalization, and did not internalize opsonized complexes.

Conclusions:

• CR1 acts as an intrinsic complement regulator on epithelial cells, effectively inhibiting both classical and alternative pathways.
• CR1's ability to regulate complement and bind immune complexes underscores its potential protective role in the kidney.
• Loss of CR1 expression on podocytes may contribute to complement-mediated kidney damage, warranting further investigation.